MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-08-2025
Surmodics ROE Ratio 2011-2026 | SRDX
Annual ROE Ratio Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.71 | -1.28 | -25.16 | 3.02 | 0.86 | 6.2 | -4.1 | 3.52 | 9.35 | 13.0 | 12.18 | 16.17 | 10.91 | -8.79 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.17 | -25.16 | 1.87 |
Quarterly ROE Ratio Surmodics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19.16 | -20.78 | -15.86 | -6.84 | -0.3 | 12.63 | 4.89 | -8.32 | -12.83 | -23.89 | -19.41 | -9.64 | -3.87 | -1.68 | 7.3 | 9.15 | 1.13 | 5.31 | -0.82 | -0.49 | 4.66 | 4.0 | 4.33 | 5.36 | 0.85 | -2.7 | -1.67 | -4.23 | -2.26 | 0.75 | -1.81 | 1.74 | 3.8 | 6.83 | 10.39 | 11.03 | 10.1 | 10.69 | 11.27 | 12.91 | 13.81 | 13.18 | 14.1 | 13.76 | 15.31 | 15.01 | 15.22 | 15.44 | 15.39 | 15.35 | 16.01 | 14.68 | -2.45 | -3.0 | -5.59 | -13.25 | 2.75 | 1.94 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.01 | -23.89 | 2.42 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M |  USA |
 |
Bioventus
BVS
|
12.35 | $ 8.93 | 0.68 % | $ 595 M | USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 13.59 | -0.44 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
4.0 | $ 25.69 | -0.54 % | $ 714 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
30.46 | $ 67.77 | 2.16 % | $ 26.4 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 153.44 | 1.05 % | $ 7.61 B | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.48 | 0.92 % | $ 931 M | USA |
 |
Guardant Health
GH
|
419.18 | $ 88.41 | 1.41 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.97 | 0.11 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 15.56 | 4.08 % | $ 470 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 16.52 | -4.45 % | $ 2.14 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 98.91 | 1.33 % | $ 8.16 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.94 | 3.52 % | $ 95.4 K | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 168.49 | 2.24 % | $ 29 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 194.82 | 1.79 % | $ 139 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 121.67 | 2.0 % | $ 19.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 198.5 | -0.23 % | $ 22 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
22.45 | $ 113.4 | 1.4 % | $ 34.5 B | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.12 | 0.45 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 9.04 | 7.36 % | $ 256 M | Israel |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.28 | 0.42 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.22 | 1.15 % | $ 2 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 79.85 | 1.71 % | $ 5.39 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.41 | 3.68 % | $ 423 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 455.2 | 0.34 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 211.79 | 1.05 % | $ 25 B |  Schweiz |
 |
Celcuity
CELC
|
-96.68 | $ 114.48 | -0.37 % | $ 4.52 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.63 | 1.32 % | $ 395 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-77.62 | $ 198.58 | 0.45 % | $ 19.5 B | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.2 | 0.42 % | $ 833 M | USA |